Business Context and Reporting Period
This Form 8-K, dated October 26, 2022, is filed by LMF Acquisition Opportunities, Inc. ("LMF") regarding its proposed business combination with SeaStar Medical, Inc. Upon closing, LMF will change its name to SeaStar Medical Holdings Corporation. The filing primarily discloses the entry into a Material Definitive Agreement (Prepaid Forward Agreement) and provides an update on shareholder redemptions.
Key Financial Metrics and Transaction Details
- Prepaid Forward Agreement: LMF, SeaStar Medical, and HB Strategies LLC ("Seller") entered into an agreement for an equity prepaid forward transaction.
- Share Volume: The agreement covers up to 700,000 "Recycled Shares" (purchased or redemption reversals) plus 50,000 "Additional Shares."
- Redemption Status: As of October 26, 2022, holders of 8,878,960 shares exercised redemption rights. Seller reversed redemption elections for 750,000 shares (700,000 Recycled + 50,000 Additional).
- Payment Terms: Seller receives a "Prepayment Amount" from LMF's trust account equal to the Number of Shares multiplied by the Per-Share Redemption Price. An additional "Share Consideration" is paid for the 50,000 Additional Shares.
- Maturity Consideration: Upon maturity, the Counterparty must pay Seller $2.50 per remaining Recycled Share (less Terminated Shares).
- Reset Price: Initially set at $10.00 per share post-closing, subject to downward adjustment based on VWAP, with a floor of $5.00.
- Break-Up Fee: If the transaction terminates under specific conditions, SeaStar Medical must pay Seller actual out-of-pocket expenses plus $1,000,000.
Material Changes and Prior Period Comparisons
This filing represents a new material agreement entered on October 26, 2022, rather than a periodic financial report. Consequently, there are no revenue, profit, or cash flow metrics to compare against a prior period. The filing notes a prior Prepaid Forward Agreement with Vellar Opportunity Fund SPV LLC (Series 4) dated October 17, 2022, under which Vellar acquired 523,000 shares plus 100,000 Additional Shares as of October 25, 2022.
Guidance, Outlook, Risks, and Contingencies
- Transaction Deadline: The Prepaid Forward Agreement may terminate if the Business Combination is not consummated by October 28, 2022.
- Ownership Cap: Seller cannot beneficially own more than 9.9% of issued and outstanding shares following the Business Combination.
- Redemption Reversals: LMF does not currently intend to permit further requests to reverse redemption elections.
- Key Risks: Risks include failure to complete the business combination by the deadline, failure to satisfy minimum trust account amounts, delisting of shares, inability to achieve profitability, and regulatory approval delays for SeaStar Medical's products.
- Forward-Looking Statements: The filing includes standard disclaimers regarding projections of future results, valuation, and product commercialization.
Investor Verification Checklist
- Verify the final number of shares redeemed versus the minimum cash requirement in the trust account to ensure the transaction can close.
- Confirm the closing date of the Business Combination relative to the October 28, 2022 termination deadline.
- Review the Form S-4 Registration Statement for detailed risk factors and the full text of the Merger Agreement.
- Monitor the stock price relative to the $10.00 Reset Price and the $5.00 floor to understand potential dilution or payout adjustments.
- Check for any subsequent filings regarding the Vellar Prepaid Forward Agreement or additional shareholder redemptions.